| 1 |
Is multidisciplinary treatment effective for hepatocellular carcinoma with portal vein tumor thrombus?Is multidisciplinary treatment effective for hepatocellular carcinoma with portal vein tumor thrombus?
Won Hyeok ChoeWon Hyeok Choe
KMSID: 1159876 J Liver Cancer. 2022;22(1):1-3. Published online 2022 March 31 DOI: http://dx.doi.org/10.17998/jlc.2022.03.15 |
|
| 4 |
Radioembolization for hepatocellular carcinoma: what clinicians need to knowRadioembolization for hepatocellular carcinoma: what clinicians need to know
Jin Woo Choi, Hyo-Cheol KimJin Woo Choi, Hyo-Cheol Kim
KMSID: 1159869 J Liver Cancer. 2022;22(1):4-13. Published online 2022 February 23 DOI: http://dx.doi.org/10.17998/jlc.2022.01.16 |
|
| 14 |
A clinical and pathological update on hepatocellular carcinomaA clinical and pathological update on hepatocellular carcinoma
Salvatore Lorenzo Renne, Luca Di TommasoSalvatore Lorenzo Renne, Luca Di Tommaso
KMSID: 1159874 J Liver Cancer. 2022;22(1):14-22. Published online 2022 March 31 DOI: http://dx.doi.org/10.17998/jlc.2022.03.18 |
|
| 23 |
Recent updates on the classification of hepatoblastoma according to the international pediatric liver tumors consensusRecent updates on the classification of hepatoblastoma according to the international pediatric liver tumors consensus
Se Un Jeong, Hyo Jeong KangSe Un Jeong, Hyo Jeong Kang
KMSID: 1159867 J Liver Cancer. 2022;22(1):23-29. Published online 2022 March 17 DOI: http://dx.doi.org/10.17998/jlc.2022.02.24 |
|
| 30 |
Diagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinomaDiagnostic performance of serum exosomal miRNA-720 in hepatocellular carcinoma
Jeong Won Jang, Ji Min Kim, Hye Seon Kim, Jin Seoub Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew YoonJeong Won Jang, Ji Min Kim, Hye Seon Kim, Jin Seoub Kim, Ji Won Han, Soon Kyu Lee, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
KMSID: 1159868 J Liver Cancer. 2022;22(1):30-39. Published online 2022 March 21 DOI: http://dx.doi.org/10.17998/jlc.2022.02.25 |
|
| 40 |
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinomaThe effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun ShimJihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
KMSID: 1159872 J Liver Cancer. 2022;22(1):40-50. Published online 2022 March 17 DOI: http://dx.doi.org/10.17998/jlc.2022.03.06 |
|
| 51 |
Complete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case reportComplete response to local therapy for advanced hepatocellular carcinoma with lung metastasis: a case report
Daeun Kim, Seiyeon Park, Won Sohn, Hyun Pyo Hong, Byung Ik KimDaeun Kim, Seiyeon Park, Won Sohn, Hyun Pyo Hong, Byung Ik Kim
KMSID: 1159878 J Liver Cancer. 2022;22(1):51-56. Published online 2022 January 27 DOI: http://dx.doi.org/10.17998/jlc.2021.12.28 |
|
| 57 |
A case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastasesA case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastases
Sang Yi Moon, Sang Young Han, Yang-Hyun BaekSang Yi Moon, Sang Young Han, Yang-Hyun Baek
KMSID: 1159877 J Liver Cancer. 2022;22(1):57-62. Published online 2022 January 6 DOI: http://dx.doi.org/10.17998/jlc.2021.12.20 |
|
| 63 |
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteriaSorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won ParkYuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
KMSID: 1159871 J Liver Cancer. 2022;22(1):63-68. Published online 2022 February 14 DOI: http://dx.doi.org/10.17998/jlc.2022.01.18 |
|
| 69 |
Concurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case reportConcurrent transarterial radioembolization and combination atezolizumab/bevacizumab treatment of infiltrative hepatocellular carcinoma with portal vein tumor thrombosis: a case report
Min Kyung Park, Su Jong YuMin Kyung Park, Su Jong Yu
KMSID: 1159873 J Liver Cancer. 2022;22(1):69-74. Published online 2022 March 21 DOI: http://dx.doi.org/10.17998/jlc.2022.03.09 |
|
| 75 |
Multidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinomaMultidisciplinary treatment with immune checkpoint inhibitors for advanced stage hepatocellular carcinoma
Ahlim Lee, Jaejun Lee, Hyun Yang, Soo-Yoon Sung, Chang Ho Jeon, Su Ho Kim, Moon Hyung Choi, Young Joon Lee, Ho Jong Chun, Si Hyun BaeAhlim Lee, Jaejun Lee, Hyun Yang, Soo-Yoon Sung, Chang Ho Jeon, Su Ho Kim, Moon Hyung Choi, Young Joon Lee, Ho Jong Chun, Si Hyun Bae
KMSID: 1159870 J Liver Cancer. 2022;22(1):75-83. Published online 2022 March 18 DOI: http://dx.doi.org/10.17998/jlc.2022.03.04 |
|
| 84 |
Long-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case reportLong-term survival after CCRT and HAIC followed by ALPPS for hepatocellular carcinoma with portal vein invasion: a case report
In-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong LimIn-Jung Kim, Sung Hwan Yoo, Jung Il Lee, Kwan Sik Lee, Hyun Woong Lee, Jin Hong Lim
KMSID: 1159875 J Liver Cancer. 2022;22(1):84-90. Published online 2022 March 22 DOI: http://dx.doi.org/10.17998/jlc.2022.03.07 |
|
